Home News Eagle Genomics and the Earlham Institute to deliver new microbiome multi-omics datasets and tools
Our website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Eagle Genomics and the Earlham Institute to deliver new microbiome multi-omics datasets and tools

by jcp
206 views
gawdo

29 September 2021

Foundational partnership enables access to novel datasets and innovation workflows through Eagle Genomics’ AI-augmented knowledge discovery platform

Cambridge and Norwich – 29 September 2021 – Today, Eagle Genomics, a pioneer in applying network science to biology, and leaders in bioscience research the Earlham Institute, are delighted to announce their new partnership focused on providing critical tools required to analyse, explore and exploit complex microbiome data. Applied across both academia and industry, the partnership will facilitate access to unique resources while accelerating data-driven collaboration.

As Eagle Genomics’ foundational knowledge partner, the Earlham Institute brings a wealth of expertise in genomics and bioinformatics, as well as developing and testing laboratory methods and computational biology pipelines to study microbial communities. The Institute has already developed a number of successful tools and datasets for bioinformaticians – such as SignalinkSalmoNetSTRONG and LotuS2.

Eagle Genomics’ platform, e[datascientist]™, applies network science to multi-dimensional life sciences data – including environmental and clinical metagenomes for multi-omics analysis. It accelerates research and development into the understanding of human-microbiome interactions to support innovation workflows, including the generation of product claims.

Anthony Finbow, CEO of Eagle Genomics, stated: “Eagle Genomics’ industry-leading open platform is helping drive the digital reinvention of life sciences R&D across numerous industries, from AgBio and food through to healthcare, personal care and beauty.

“Our partnership with the Institute is a clear demonstration of our commitment to enable a radical, global shift in microbiome science-led innovation. By harnessing nature – including its complex networks and associated multi-dimensional data – we can help tackle the world’s Grand Challenges while unlocking significant economic potential.”

Dr Liliya Serazetdinova, Head of Business Development and Impact at the Earlham Institute, said: “This partnership is part of a big data revolution in terms of how multi-omics data will be accessed and analysed – combining open science and commercial R&D to benefit each partner and society.

“Eagle Genomics’ e[datascientist]™ platform gives our scientists the opportunity to share their work more widely, establish new connections, and use it as a testing ground – interrogating and integrating new datasets, as well as developing new tools and pipelines – to further advance our research and apply to the biotech industry.

“We’re really excited to be working with Eagle Genomics and look forward to seeing how this platform evolves, and involves more partners in the coming months.”

Eagle Genomics’ partnership with the Earlham Institute will range from collaborative R&D to consultancy work and licensing, as well as deploying e[datascientist]’s hosting and networking capabilities. It will also provide strategic insight as part of a steering group on new pipelines, and for example, could include research into:

* Classification and genome reconstruction in complex environments
* Biological signalling network resources for human and model organisms
* Global patterns of antimicrobial resistance found in microbes
* Investigating the persistence and evolution of human associated microbes

Dr Andrew Tingey, Senior Director, Global Licensing and IP Strategy at Eagle Genomics, said: “At Eagle, we’re using network science and world-leading AI tools to unlock the potential for innovation from complex multi-dimensional microbiome data. Our new partnership with the Earlham Institute will help support the global microbiome R&D community while shaping the future of metagenomics, linking world-leading bioinformatics pipelines, tools, and datasets.”

“We are delighted that the Earlham Institute is partnering with us, on our journey towards creating an open platform for data innovation.”

Eagle Genomics is currently in discussions with a range of other organisations to ensure that its platform continues to evolve as the burgeoning global life sciences knowledge discovery hub.

www.gawdo.com

You may also like